RANI THERAPEUTICS HOLDINGS INC. - CLASS A COMMON
2,3100
14-ноября-24 12:31:06
15 мин. задержка
Акции
-0,1600
-6,48%
Сегодняшний диапазон
2,2600 - 2,4700
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study
06 дек 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the Stifel Healthcare Conference
09 ноя 2022 16:05:02 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update
24 окт 2022 08:30:00 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock
11 авг 2022 23:47:30 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock
10 авг 2022 17:28:34 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update
10 авг 2022 16:28:17 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis
10 авг 2022 16:23:29 Источник Nasdaq GlobeNewswire
-
08 авг 2022 08:30:00 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update
11 май 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at Upcoming Investor Conferences
03 май 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
03 май 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
07 апр 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
29 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
23 мар 2022 20:38:02 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis
23 мар 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
23 фев 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Appoints Lisa Rometty to Board of Directors
07 янв 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update
15 ноя 2021 19:31:25 Источник Nasdaq GlobeNewswire